A Modifying Autoantigen in Graves' Disease.


Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 10 12 2018
accepted: 26 02 2019
pubmed: 2 3 2019
medline: 18 12 2019
entrez: 2 3 2019
Statut: ppublish

Résumé

The TSH receptor (TSHR) is the major autoantigen in Graves' disease (GD). Bioinformatic analyses predict the existence of several human TSHR isoforms from alternative splicing, which can lead to the coexpression of multiple receptor forms. The most abundant of these is TSHRv1.3. In silico modeling of TSHRv1.3 demonstrated the structural integrity of this truncated receptor isoform and its potential binding of TSH. Tissue profiling revealed wide expression of TSHRv1.3, with a predominant presence in thyroid, bone marrow, thymus, and adipose tissue. To gain insight into the role of this v1.3 receptor isoform in thyroid pathophysiology, we cloned the entire open reading frame into a mammalian expression vector. Immunoprecipitation studies demonstrated that both TSHR-stimulating antibody and human TSH could bind v1.3. Furthermore, TSHRv1.3 inhibited the stimulatory effect of TSH and TSHR-Ab MS-1 antibody on TSHR-induced cAMP generation in a dose-dependent manner. To confirm the antigenicity of v1.3, we used a peptide ELISA against two different epitopes. Of 13 GD samples, 11 (84.6%) were positive for a carboxy terminal peptide and 10 (76.9%) were positive with a junction region peptide. To demonstrate that intracellular v1.3 could serve as an autoantigen and modulate disease, we used double-transfected Chinese hamster ovary cells that expressed both green fluorescent protein (GFP)-tagged TSHRv1.3 and full-length TSHR. We then induced cell stress and apoptosis using a TSHR monoclonal antibody and observed the culture supernatant contained v1.3-GFP protein, demonstrating the release of the intracellular receptor variant by this mechanism.

Identifiants

pubmed: 30822352
pii: 5366832
doi: 10.1210/en.2018-01048
pmc: PMC6455603
doi:

Substances chimiques

Autoantibodies 0
Autoantigens 0
Immunoglobulins, Thyroid-Stimulating 0
Protein Isoforms 0
Receptors, Thyrotropin 0
thyrotropin-binding inhibitory immunoglobulin 0
Thyrotropin 9002-71-5

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1008-1020

Subventions

Organisme : BLRD VA
ID : I01 BX000800
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK069713
Pays : United States

Informations de copyright

Copyright © 2019 Endocrine Society.

Références

EMBO J. 2005 Jun 1;24(11):1954-64
pubmed: 15889138
Thyroid. 2015 Apr;25(4):455-61
pubmed: 25585054
Endocrine. 1995 Mar;3(3):233-40
pubmed: 21153200
Genome Res. 2002 Apr;12(4):656-64
pubmed: 11932250
Hum Mol Genet. 2009 May 1;18(9):1704-13
pubmed: 19244275
Acta Endocrinol (Copenh). 1980 May;94(1):58-63
pubmed: 6247874
J Endocrinol Invest. 2004 Mar;27(3):216-20
pubmed: 15164996
J Autoimmun. 2013 Jun;43:18-25
pubmed: 23538203
Endocr J. 2002 Apr;49(2):175-80
pubmed: 12081236
Thyroid. 1993 Fall;3(3):219-24
pubmed: 8257862
J Endocrinol. 1993 Nov;139(2):317-28
pubmed: 8308468
Eur J Biochem. 2003 Sep;270(17):3486-97
pubmed: 12919313
Biochem Biophys Res Commun. 1992 Nov 16;188(3):1214-9
pubmed: 1445355
Horm Metab Res. 2018 Dec;50(12):863-870
pubmed: 30396220
J Clin Invest. 2005 Aug;115(8):1972-83
pubmed: 16075037
Endocrinology. 1996 Sep;137(9):3915-20
pubmed: 8756566
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Biol Chem. 2001 Nov 30;276(48):45217-24
pubmed: 11535591
Sci Signal. 2018 Jan 23;11(514):
pubmed: 29363585
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
Thyroid. 2007 Oct;17(10):923-38
pubmed: 17900238
BMC Bioinformatics. 2008 Jul 18;9:313
pubmed: 18638396
J Clin Invest. 2002 Dec;110(11):1667-74
pubmed: 12464672
Cell. 2003 Oct 17;115(2):151-62
pubmed: 14567913
J Clin Endocrinol Metab. 1994 Nov;79(5):1234-8
pubmed: 7962314
J Autoimmun. 2015 Nov;64:82-90
pubmed: 26235382
J Biol Chem. 1999 Jan 1;274(1):101-7
pubmed: 9867816
Genome Res. 2001 May;11(5):889-900
pubmed: 11337482
Trends Biotechnol. 2003 Aug;21(8):346-53
pubmed: 12902171
Nat Genet. 2000 Apr;24(4):340-1
pubmed: 10742092
Cell. 2000 Oct 27;103(3):367-70
pubmed: 11081623
N Z Med J. 1956 Feb;55(305):36-41
pubmed: 13309737
Endocrinology. 1999 Oct;140(10):4516-20
pubmed: 10499506
Trends Genet. 2001 Feb;17(2):100-7
pubmed: 11173120
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Endocrinology. 2015 Feb;156(2):488-98
pubmed: 25406938
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12562-7
pubmed: 25122677
Hum Mol Genet. 2005 Oct 15;14(20):2991-3002
pubmed: 16135555
Thyroid. 1998 May;8(5):411-3
pubmed: 9623732
Endocrinology. 1962 Jun;70:801-5
pubmed: 13859304
Thyroid. 2007 May;17(5):395-410
pubmed: 17542669
J Biol Chem. 1977 Nov 25;252(22):7967-70
pubmed: 914855
Biochem Biophys Res Commun. 1989 Dec 29;165(3):1184-90
pubmed: 2558651
Thyroid. 1995 Apr;5(2):101-5
pubmed: 7647568
Protein Sci. 1994 Sep;3(9):1582-96
pubmed: 7833817
Biochem Biophys Res Commun. 1992 Sep 16;187(2):1135-43
pubmed: 1530609
J Autoimmun. 2013 Dec;47:17-24
pubmed: 23958398
Thyroid. 2010 Jul;20(7):727-36
pubmed: 20578897
Biochem Biophys Res Commun. 1990 Jan 15;166(1):394-403
pubmed: 2302212
Science. 1989 Dec 22;246(4937):1620-2
pubmed: 2556796
Clin Exp Immunol. 2017 May;188(2):243-253
pubmed: 28099999
Lancet. 1975 May 24;1(7917):1201
pubmed: 48829
Genes Dev. 2003 Feb 15;17(4):419-37
pubmed: 12600935
Science. 1989 Aug 4;245(4917):525-8
pubmed: 2502844
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Best Pract Res Clin Endocrinol Metab. 2005 Mar;19(1):33-52
pubmed: 15826921
J Comput Chem. 2010 Nov 15;31(14):2658-68
pubmed: 20740566
Endocr Rev. 1998 Dec;19(6):673-716
pubmed: 9861544
Endocr Rev. 1992 Aug;13(3):596-611
pubmed: 1425489
Biochem Biophys Res Commun. 1989 Dec 29;165(3):1250-5
pubmed: 2610690
Horm Metab Res. 2015 Sep;47(10):753-66
pubmed: 26361261
Hum Mol Genet. 2011 Sep 1;20(17):3415-23
pubmed: 21642385
J Clin Endocrinol Metab. 1997 Jun;82(6):2003-5
pubmed: 9177421
Nucleic Acids Res. 2001 Jul 1;29(13):2850-9
pubmed: 11433032
Front Endocrinol (Lausanne). 2016 Jan 28;7:3
pubmed: 26858688

Auteurs

Rauf Latif (R)

Thyroid Research Unit, Icahn School of Medicine at Mount Sinai, New York, New York.
James J. Peters VA Medical Center, New York, New York.

Mihaly Mezei (M)

Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, New York.

Syed A Morshed (SA)

Thyroid Research Unit, Icahn School of Medicine at Mount Sinai, New York, New York.
James J. Peters VA Medical Center, New York, New York.

Risheng Ma (R)

Thyroid Research Unit, Icahn School of Medicine at Mount Sinai, New York, New York.
James J. Peters VA Medical Center, New York, New York.

Rachel Ehrlich (R)

Thyroid Research Unit, Icahn School of Medicine at Mount Sinai, New York, New York.

Terry F Davies (TF)

Thyroid Research Unit, Icahn School of Medicine at Mount Sinai, New York, New York.
James J. Peters VA Medical Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH